ISSN - 0973-0958

Pediatric Oncall Journal

SARS-CoV-2 Infection in Neonates Presenting as Sepsis with Deranged Inflammatory Markers 01/06/2021 00:00:00 https://www.pediatriconcall.com/Journal/images/journal_cover.jpg

SARS-CoV-2 Infection in Neonates Presenting as Sepsis with Deranged Inflammatory Markers

Ambike Deepali, Sayyad Rijwana.
Department of Pediatrics, Postgraduate Institute & Yashwantrao Chawan Memorial Hospital, Pimpri, Pune, Maharashtra, India.

ADDRESS FOR CORRESPONDENCE
Dr Deepali Ambike, Professor & Head, Department of Pediatrics, Postgraduate Institute & Yashwantrao Chawan Memorial Hospital, Pimpri, Pune, Maharashtra, India.
Email: ambikedeepa@gmail.com
Keywords
SARS CoV-2, Neonate, Sepsis
 
Symptomatic coronavirus 2019 (COVID-19) disease due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in neonates is rare.1 Neonates may acquire infection either by vertical transmission from mother or by horizontal transmission.2 We report two term babies with SARS CoV-2 infection who presented as sepsis.
Case 1 was a female preterm neonate born at 34 weeks of gestation with birth weight 1.70 kg referred from a private hospital neonatal intensive care unit (NICU) on day 12 of life in April 2020. Mother was not tested for Covid-19 before delivery. SARS CoV-2 was positive by RT-PCR on oropharyngeal and nasal swab in both neonate and mother; hence baby was shifted to our NICU. On admission, baby was maintaining oxygen saturation of 100% at room air, there was no respiratory distress, but suck was poor. All serial laboratory parameters are depicted in Table 1. White cell counts were high with high CRP titre though chest X-ray was normal. Blood culture grew Klebsiella Pneumoniae. Treatment was initiated as per Maharashtra Covid-19 Task force recommendations3 with oral azithromycin and oral oseltamivir. Intravenous antibiotics as per NICU protocol was given (table 1). She also received packed red blood cell (PRBC) and platelet transfusion d-dimer which was high on admission came down to normal after injectable dexamethasone (0.1 mg/kg/day) for 5 days. Baby was discharged after 14 days and was stable and accepting feeds. Case 2 was a male child born at full term by normal vaginal delivery with birth weight of 3 kg to a COVID-19 infected mother in our hospital. He developed tachypnea after 24 hours of life. At birth RT PCR for SARS CoV-2 was negative in the baby by oropharyngeal and nasal swab. Baby was given oxygen by continuous positive airway pressure (CPAP). Serial laboratory parameters are depicted in Table1.After 8 days of admission, tachypnea still persisted and baby started coughing. Repeat oropharyngeal and nasal swab were positive for SARS CoV-2 by RT-PCR, but chest X-Ray was normal. Treatment as per Maharashtra Government Covid-19 Task force guidelines3 was initiated along with injectable dexamethasone 0.1 mg/kg/day for 5 days to which the patient responded, and patient was discharged on Day 19 of life.

Table 1. Serial laboratory parameters of both patients
Investigations Case 1 Case 2
Days after birth Day 12 Day 14 Day 15 Day 19 Day 24 Day 2 Day 3 Day 9 Day 19
Hemoglobin (g/dl) 10.7 12.1 13.8 - 15.0 15.6 15.3 16.7 -
Hematocrit (%) 42.4 38.9 35.0 - 47.3 48 51.4 51.6 -
Total leucocyte count (cells/cumm) 29,200 13,100 13,700 - 11,500 18,600 12,600 10,400 -
Neutrophil to Lymphocyte Ratio 0.7 0.43 0.4 - 0.3 1.6 1.2 0.37 -
Platelets (cells/cumm) 27,300 144,000 142,000 - 270,000 196,000 198,000 216,000 -
Fibrinogen (Normal 2.7-2.8 g/l) 3.1 3.2 - 2.9 - 2.82 1.8 - -
D-dimer( Normal 0.1-0.5 mg/l) 0.6 0.6 0.1 0.1 - 0.7 0.4 0.4 -
C-reactive protein ( Normal 0-0.6 mg/ dl) - 15   67 45 1.9 1
Blood culture Klebsiella Pneumoniae No growth
Antibacterial agents Inj meropenem & metronidazole. Inj ceftazidime added as per blood culture sensitivity report. Cefotaxime & Amikacin for 7 days and Piperacillin added on Day 8 empirically as baby deteriorated clinically.
Urine routine Normal Normal
Baby RT PCR for COVID-19 Positive ( day 11) Negative (day 21) Negative   Positive Negative


Late neonatal SARS-CoV-2 infection with clinically significant hypoxemia without overt signs of respiratory distress that required oxygen therapy was reported by Mariateresa Sinelli et al.1 The mode of transmission of SARS-CoV-2 in our patients could not be determined. We had not done an RT-PCR for SARS-CoV-2 virus on cord blood and placenta of our patients to determine whether it was intrauterine transmission.3 Horizontal transmission cannot be ruled out in our patients similar to study by James cook et al.2 Since both the babies were detected to be COVID-19 infected after8-12 days of life, it is possible that transmission occurred after birth. Both our patients had normal chest X-ray. However, In the Wuhan study4, 12 out of 13 neonates presented with radiological features for pneumonia, 1 with occasional cough similar to our case 2. Recent literature shows that d-dimer, fibrinogen, CRP values are often increased in patients with COVID-19 similar to our cases, which was reported to be 44.9% in a meta-analysis5 even in patients with milder forms, and therefore, d-dimer measurement may be associated with a worsening clinical picture. The role of steroids and antivirals in neonatal covid was still not established when these patients presented, however in view of hyperinflammatory response involved, we tried short-term dexamethasone therapy for the elevated CRP and d-dimer levels and worsening hypoxemia6.7 to which our patients responded.


 
Compliance with Ethical Standards
Funding None
 
Conflict of Interest None
 
  1. Sinelli M, Paterlini G, Citterio M, Di Marco A, Fedeli T, Ventura ML. Early Neonatal SARS-CoV-2 Infection Manifesting with Hypoxemia Requiring Respiratory Support. Pediatrics. 2020;146:e20201121.  [CrossRef]  [PubMed]
  2. Cook J, Harman K, Zoica B, Verma A, D'Silva P, Gupta A. Horizontal transmission of severe acute respiratory syndrome coronavirus 2 to a premature infant: multiple organ injury and association with markers of inflammation. Lancet Child Adolesc Health. 2020;4:548-551.  [CrossRef]
  3. Medical Education and Drugs Department-Government of Maharashtra. OPERATIONAL MODULE FOR COVID-19 FACILITY IN MAHARASHTRA. Version_1.1 Date 8 April 2020. Available from URL: https://www.mgims.ac.in/files/covid/MEDD_operational_module.pdf. Accessed on 21st February 2021
  4. Wu YT, Liu J, Xu JJ, Chen YF, Yang W, Chen Y, et al. Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China. PLoS Med. 2020;17:e1003195.  [CrossRef]  [PubMed]  [PMC free article]
  5. Karimian M, Jamshidbeigi A, Badfar G, Azami M. Laboratory findings in coronavirus disease 2019 (COVID-19) patients: a comprehensive systematic review and meta-analysis. medRxiv 2020.06.07.20124602; doi: https://doi.org/10.1101/2020.06.07.20124602  [CrossRef]
  6. Molloy EJ, Lavizzari A, Klingenberg C, Profit J, Zupancic JAF, Davis AS, Mosca F, Bearer CF, Roehr CC; International Neonatal COVID-19 Consortium. Neonates in the COVID-19 pandemic. Pediatr Res. 2020 Aug 3. doi: 10.1038/s41390-020-1096-y.  [CrossRef]  [PMC free article]
  7. Selvaraj V, Dapaah-Afriyie K, Finn A, Flanigan T. Short-Term Corticosteroids in SARS-CoV2 Patients: Hospitalists' Perspective. medRxiv 2020.06.19.20109173; doi: https://doi.org/10.1101/2020.06.19.20109173  [CrossRef]



DOI: https://doi.org/10.7199/ped.oncall.2022.2

Cite this article as:
Deepali A, Rijwana S. SARS-CoV-2 Infection in Neonates Presenting as Sepsis with Deranged Inflammatory Markers. Pediatr Oncall J. 2021 Mar 04. doi: 10.7199/ped.oncall.2022.2
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0